Evidence map›Paper›PMID 30289941›Full record

ArticlePloS one2018

The aqueous extract of Phellinus igniarius (SH) ameliorates dextran sodium sulfate-induced colitis in C57BL/6 mice.

Yuqing Sun, Shi Zhong, Jiaqi Yu, Jianxun Zhu, Dongfeng Ji, Guiyan Hu, Chongming Wu, Yougui Li

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Anti-Gout Effects of the Medicinal FungusFrontiers in pharmacology · 2021
    Article
  12. Impact ofPeerJ · 2020
    Article
  13. Review
  14. Frontiers in immunology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yuqing SunSericultural Research Institute, Zhejiang Academy of Agricultural Science, Hangzhou, China.
Shi ZhongSericultural Research Institute, Zhejiang Academy of Agricultural Science, Hangzhou, China.
Jiaqi YuPharmacology and Toxicology Research Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Jianxun ZhuSericultural Research Institute, Zhejiang Academy of Agricultural Science, Hangzhou, China.
Dongfeng JiSericultural Research Institute, Zhejiang Academy of Agricultural Science, Hangzhou, China.
Guiyan HuSericultural Research Institute, Zhejiang Academy of Agricultural Science, Hangzhou, China.
Chongming WuPharmacology and Toxicology Research Center, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID 0000-0003-2898-370X
Yougui LiSericultural Research Institute, Zhejiang Academy of Agricultural Science, Hangzhou, China.
Sericultural Research Institute · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phellinus igniarius, which is called Sanghuang in Chinese, is a fungal herb widely used in Traditional Chinese Medicine to treat stomachache, inflammation and tumors. Recent studies have demonstrated the antitumor, anti-diabetic, anti-inflammatory and immunity-modulating activities of P. igniarius. In the present study, we investigated that ameliorating effect of the aqueous extract of P. igniarius fruiting body (SH) on dextran sodium sulfate (DSS)-induced colitis in C57BL/6 mice. Treatment with SH (250 and 400 mg/kg) for 8 weeks effectively alleviated the pathological indicators of colitis such as bodyweight reduction, disease activity index score, shortening of colon length and abnormal colon histology. The plasma levels of lipopolysaccharide (LPS) and inflammatory factors such as interleukin-6 (IL-6), IL-1β and tumor necrosis factor (TNF)-α were all significantly reduced. Supplementation of SH (10 mg/L) also inhibited LPS-elicited IL-1β production by RAW264.7 macrophages. Real-time PCR and western blot showed that treatment with SH significantly inhibited the phosphorylation of nuclear factor kappa B inhibitor alpha (IκBα) and decreased the expression of IL-6/IL-1β-maturation genes such as apoptosis-associated speck-like protein (ASC3) and caspase-1 in the colon of DSS-induced colitis mice. These results suggest that SH is adequate for the treatment of colitis. Inhibiting the expression and release of inflammatory factors may participate in the colitis-ameliorating effect of SH.

Indexed as

AnimalsBasidiomycotaCaspase 1ColitisColonDextran SulfateInterleukin-1betaInterleukin-6MacrophagesMiceMice, Inbred C57BLNF-KappaB Inhibitor alphaPhosphorylationRAW 264.7 CellsTranscription, GeneticTumor Necrosis Factor-alphaCaspase 1Dextran SulfateInterleukin-1betaInterleukin-6NF-KappaB Inhibitor alphaTumor Necrosis Factor-alpha

Identifiers

PMID30289941
PMCPMC6173430
OpenAlexW2895295850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.